BeOne Medicines Income Statement (2015-2026) | ONC

Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
149.99M206.44M213.98M306.63M341.57M387.63M380.10M447.80M595.26M781.31M634.41M751.65M929.17M1,001.60M1,127.82M1,117.28M1,315.30M1,412.28M1,498.17M1,513.44M
Cost of Revenue (Quarter)
36.26M47.41M48.55M65.24M71.17M76.54M73.52M81.79M95.99M96.31M105.83M124.94M138.13M170.46M160.56M165.00M164.61M196.51M142.42M167.22M
Gross Profit (Quarter)
113.73M159.03M165.43M241.39M270.40M311.08M306.57M366.01M499.27M685.00M528.58M626.72M791.03M831.14M967.26M952.28M1,150.69M1,215.77M1,355.75M1,346.22M
Operating items
Amortization - Intangibles (Quarter)
0.30M0.40M0.19M0.19M0.19M0.19M-2.26M0.99M1.03M1.29M-0.78M
Research & Development (Quarter)
356.09M351.94M-556.29M389.92M378.21M426.36M446.02M408.58M422.76M453.26M493.99M460.64M454.47M496.18M542.01M481.89M524.90M523.66M615.42M541.22M
Selling, General & Administrative (Quarter)
232.29M269.23M-479.65M294.57M331.40M322.89M329.74M328.50M395.03M365.71M418.38M427.43M443.73M455.22M504.68M459.29M537.91M529.00M555.29M555.10M
Other Operating Expenses (Quarter)
36.45M47.60M-116.92M65.42M71.36M76.73M-213.52M0.19M0.19M
Operating Expenses (Quarter)
624.83M668.76M-1152.86M749.91M780.97M825.99M562.24M737.27M817.99M818.97M912.37M888.07M898.20M951.40M1,046.69M941.17M1,062.81M1,052.66M1,170.71M1,096.32M
Operating Income (Quarter)
-474.84M-462.32M190.56M-443.29M-439.40M-438.36M-468.62M-371.26M-318.71M-133.97M-383.80M-261.35M-107.16M-120.27M-79.42M11.10M87.89M163.11M185.03M249.90M
EBIT (Quarter)
-474.84M-462.32M190.56M-443.29M-439.40M-438.36M-468.62M-371.26M-318.71M-133.97M-383.80M-261.35M-107.16M-120.27M-79.42M11.10M87.89M163.11M185.03M249.90M
Non-operating items
Interest & Investment Income (Quarter)
26.65M20.64M16.16M13.22M10.64M29.61M12.85M3.50M3.03M58.13M27.66M
Other Non Operating Income (Quarter)
-0.87M31.48M-800.16M11.97M-129.62M-125.64M19.44M18.30M-63.82M336.66M16.75M1.76M-11.98M11.32M-13.73M3.95M8.17M-18.98M-35.69M14.54M
Non Operating Income (Quarter)
-0.87M31.48M-800.16M11.97M-129.62M-125.64M19.44M18.30M-63.82M336.66M16.75M1.76M-11.98M11.32M-13.73M3.95M8.17M-18.98M-35.69M14.54M
Net income details
EBT (Quarter)
-480.57M-433.08M-606.03M-421.25M-557.59M-551.24M-430.96M-336.94M-367.46M229.34M-350.77M-243.43M-105.92M-98.30M-85.35M20.90M99.55M147.16M149.24M259.21M
Tax Provisions (Quarter)
-0.23M5.04M-15.35M13.95M8.14M6.32M14.37M11.49M13.67M13.93M16.78M7.72M14.48M23.05M66.53M19.63M5.23M22.32M82.74M31.86M
Profit After Tax (Quarter)
-480.34M-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M
Equity Income (Quarter)
-2.33M23.76M-9.53M-16.97M-5.91M-2.95M-5.58M-0.17M0.47M-2.67M-3.95M
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)
-480.34M-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M
Consolidated Net Income (Quarter)
-480.34M-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M
Income towards Parent Company (Quarter)
-480.34M-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M
Net Income towards Common Stockholders (Quarter)
-480.34M-438.11M-590.68M-435.20M-565.73M-557.56M-445.33M-348.43M-381.14M215.41M-367.55M-251.15M-120.41M-121.35M-151.88M1.27M94.32M124.84M66.50M227.36M
Additional items
EPS (Basic) (Quarter)
-0.40-0.36-0.49-0.33-0.42-0.41-0.33-0.26-0.280.16-0.27-0.19-0.09-0.09-0.110.070.090.040.16
EPS (Weighted Average and Diluted) (Quarter)
-0.40-0.36-0.49-0.33-0.42-0.41-0.33-0.26-0.280.15-0.27-0.19-0.09-0.09-0.110.060.080.040.15
Shares Outstanding (Weighted Average) (Quarter)
Shares Outstanding (Diluted Average) (Quarter)
EBITDA (Quarter)
-474.84M-462.32M190.56M-443.29M-439.40M-438.36M-468.62M-371.26M-318.71M-133.97M-383.80M-261.35M-107.16M-120.27M-79.42M11.10M87.89M163.11M185.03M249.90M
Interest Expenses (Quarter)
7.00M32.89M
Tax Rate (Quarter)
0.05%-1.16%2.53%-3.31%-1.46%-1.15%-3.33%-3.41%-3.72%6.07%-4.78%-3.17%-13.68%-23.44%-77.95%93.92%5.25%15.17%55.44%12.29%